News, analysis and comment from the Financial Times, the worldʼs leading global business publication
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
Slow pace of immunisation criticised while jab makers warn of supply bottlenecks
As the battles against cancer and Covid-19 make clear, breakthroughs depend on basic research and good policies
Scientists hope spotlight will boost sector similar to Nasa’s Apollo programme in 1960s
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
Increase in demand for ancient treatment proves contentious even as it reflects frustration with conventional medicine
Vital treatment is being held up as the crisis consumes health service resources
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
New strain of virus is 70 per cent more transmissible but seemingly no more deadly after its detection in UK and elsewhere